Auricularia polytricha polysaccharides induce cell cycle arrest and apoptosis in human lung cancer A549 cells

International Journal of Biological Macromolecules

Volumn 68, Issue , 2014, Pages 67-71

  Yu, Jie ^a   Sun, Ruilin ^b   Zhao, Zhongquan ^c   Wang, Yingyu ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FUZHOU GENERAL HOSPITAL   (China)

Author keywords

Apoptosis; Auricularia polytricha; Lung cancer; Polysaccharide

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLYSACCHARIDE; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AURICULARIA POLYTRICHA; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DNA SYNTHESIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMIDIFIER; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; LUNG CANCER; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BASIDIOMYCETES; CELL CYCLE CHECKPOINT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BASIDIOMYCOTA; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; G0 PHASE; G1 PHASE; HUMANS; LUNG NEOPLASMS; MICE, INBRED BALB C; MICE, NUDE; POLYSACCHARIDES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899792812     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2014.04.018     Document Type: Article

References (18)

1. Yamanaka R. Medical management of brain metastases from lung cancer (Review). Oncology Reports 2009, 22:1269-1276.
2. Stupp R., Monnerat C., Turrisi A.T., Perry M.C., Leyvraz S. Small cell lung cancer: State of the art and future perspectives. Lung Cancer 2004, 45:105-117.
3. Chrystal K., Cheong K., Harper P. Chemotherapy for small-cell lung cancer: state of the art. Current Opinion in Oncology 2004, 16:136-140.
4. Gilsson B.S. Recurrent small-cell lung cancer: Update. Seminars in Oncology 2003, 30:72-78.
5. Schwartsmann G., Ratain M.J., Cragg G.M., Wong J.E., Saijo N., Parkinson D.R., Fujiwara Y., Pazdur R., Newman D.J., Dagher R., Di Leone L. Anticancer drug discovery and development throughout the world. Journal of Clinical Oncology 2002, 20:47S-59S.
6. Sheu F., Chien P.J., Chien A.L., Chen Y.F., Chin K.L. Isolation and characterization of an immunomodulatory protein (APP) from the Jew's Ear mushroom Auricularia polytricha. Food Chemistry 2004, 87:593-600.
7. Sun Y.X., Li T.B., Liu J.C. Structural characterization and hydroxyl radicals scavenging capacity of a polysaccharide from the fruiting bodies of Auricularia polytricha. Carbohydrate Polymers 2010, 80:377-380.
8. Yu M.Y., Xu X.Y., Qing Y., Luo X., Yang Z.R., Zheng L.Y. Isolation of an anti-tumor polysaccharide from Auricularia polytricha (jew's ear) and its effects on macrophage activation. European Food Research and Technology 2009, 228:477-485.
9. Hussain R.F., Nouri A.M., Oliver R.T. A new approach for measurement of cytotoxicity using colorinetric assay. Journal of Immunological Methods 1993, 160:89-96.
10. Ran Z.H., Xu Q., Tong J.L., Xiao S.D. Apoptotic effect of epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway. World Journal of Gastroenterology 2007, 13:4255-4259.
11. Qi F., Li A., Zhao L., Xu H., Inagaki H., Wang D., Cui X., Gao B., Kokudo N., Nakata M., Tang W. Cinobufacini, an aqueous extract from Bufo bufo gargarizans Cantor, induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells. Journal of Ethnopharmacology 2010, 128:654-661.
12. Osborne C.K., Coronado-Heinsohn E.B., Robinson J.P. Human breast cancer in the athymic nude mouse: Cytostatic effects of long-term anti-estrogen therapy. European Journal of Cancer and Clinical Oncology 1987, 23:1189-1196.
13. Guadagno T.M., Newport J.W. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 1996, 84:73-82.
14. May P., May E. Twenty years of p53 research: Structural and functional aspects of the p53 protein. Oncogene 1999, 18:7621-7636.
15. Toogood P.L. Cyclin-dependent kinase inhibitors for treating cancer. Medicinal Research Reviews 2001, 21:487-498.
16. Green D.R., Reed J.C. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
17. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
18. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D.R., Poirier G.G., Salvesen G.S., Dixit V.M. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81:801-809.